Company profile: SciFluor
1.1 - Company Overview
Company description
- Provider of fluorination technologies that improve drug properties, such as metabolic stability and potency.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SciFluor
Innate Pharma
HQ: France
Website
- Description: Provider of first-in-class immunotherapy drug candidates for cancer and inflammatory diseases, specializing in novel monoclonal antibodies and NK cell engagers targeting innate immunity pathways. Pipeline includes ANKET; Lacutamab for cutaneous and peripheral T cell lymphomas; Monalizumab (anti-NKG2A) and CD39 with AstraZeneca for NSCLC and other solid tumors; CD123 and B7-H3 multi-specific ANKETs with Sanofi.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Innate Pharma company profile →
Biotest
HQ: Germany
Website
- Description: Provider of plasma proteins and biotherapeutic drugs for haematology, clinical immunology and intensive care medicine, developing, manufacturing and marketing immunoglobulins and clotting factors, with a value chain extending from pre-clinical and clinical development to worldwide marketing and distribution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotest company profile →
Q BioMed
HQ: United States
Website
- Description: Provider of radiopharmaceutical and therapeutic candidates, including Strontium-89 Chloride Injection for relief of bone pain from skeletal metastases; Uttroside-B, a chemotherapeutic agent under development for liver cancer; QBM-001, a preclinical candidate targeting pediatric minimally verbal autism spectrum disorder; and MAN-01, a preclinical topical eyedrop for glaucoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q BioMed company profile →
Orbis Biosciences
HQ: United States
Website
- Description: Provider of scalable materials encapsulation solutions, enabling precise control of particle size, encapsulation material, shell thickness, and porosity for applications in drug formulations, agricultural compounds, and novel food processing techniques.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orbis Biosciences company profile →
Pearl Therapeutics
HQ: United States
Website
- Description: Provider of unique dual and triple combination inhaled therapies for widely prevalent respiratory diseases, including chronic obstructive pulmonary disease, delivered via familiar metered dose inhalers to broaden patient access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pearl Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SciFluor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SciFluor
2.2 - Growth funds investing in similar companies to SciFluor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SciFluor
4.2 - Public trading comparable groups for SciFluor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →